Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 8/20 | 0.38 |
| ▸ | STAT3 | P40763 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.34 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.34 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | RGS12 | O14924 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1263847 | 0.97 | TERT (0.36) | TERTSTAT3HIF1ANFE2L2KEAP1 | |
| SCHEMBL12672596 | 0.91 | TERT (0.33) | TERTNFE2L2KEAP1TLR9 | |
| SCHEMBL19205403 | 0.85 | TERT (0.40) | TERTSTAT3HIF1ANFE2L2KEAP1 | |
| SCHEMBL19205464 | 0.85 | TERT (0.40) | TERTSTAT3HIF1ANFE2L2KEAP1 | |
| SCHEMBL12659772 | 0.84 | — | — | |
| SCHEMBL1264268 | 0.84 | TERT (0.41) | TERTSTAT3HIF1ANFE2L2KEAP1 | |
| SCHEMBL17514446 | 0.84 | TP53 (0.36) | NFE2L2KDM4EALOX15 | |
| SCHEMBL17514391 | 0.83 | POLB (0.32) | ALDH1A1KDM4E | |
| SCHEMBL19205460 | 0.82 | NFE2L2 (0.38) | TERTSTAT3HIF1ANFE2L2KEAP1 | |
| SCHEMBL19205475 | 0.82 | TERT (0.38) | TERTSTAT3HIF1ANFE2L2KEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7893265-B2 | Imidation of derivatives of anthracene-2,3:6,7-dianhydride, napthalene-1,4:5,8-dianhydride, or perylene-3,4:9,10-anhydride with primary amine to perylene-bis(dicarboximide)s, naphthalene-bis(dicarboximide)s, and anthracene-bis(dicarboximide)s and/or coronene-bis(dicarboximide)s; electronics, composites | POLYERA CORPORATION (US) | 2011-02-22 | — | — | US | claimed |
| US-20080177073-A1 | Methods for preparing arene-BIS (dicarboximide)-based semiconducting materials and related intermediates for preparing same | USINVEST LLC | 2008-07-24 | — | — | US | claimed |
| EP-3183250-B1 | PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL | CLAP CO LTD (KR) | 2023-10-04 | — | — | EP | disclosed |
| EP-3183757-B1 | ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING LIQUID MEDIUM | CLAP CO LTD (KR) | 2022-05-04 | — | — | EP | disclosed |
| US-10454037-B2 | Organic semiconductor composition comprising a liquid medium | BASF SE (DE) | 2019-10-22 | — | — | US | disclosed |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | BASF SE (DE) | 2019-03-05 | — | — | US | disclosed |
| US-20170250347-A1 | ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING A LIQUID MEDIUM | BASF SE (DE) | 2017-08-31 | — | — | US | disclosed |
| US-20170237005-A1 | PROCESS FOR PREPARING A CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL | BASF SE (DE) | 2017-08-17 | — | — | US | disclosed |
| EP-3183250-A1 | PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL | BASF SE (DE) | 2017-06-28 | — | — | EP | disclosed |
| WO-2016027218-A1 | PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL | BASF SE (DE) | 2016-02-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080177073-A1 | Methods for preparing arene-BIS (dicarboximide)-based semiconducting materials and related intermediates for preparing same | RECQL, CCNE2, CCNE1 | TERT 184/4885STAT3 4545/4885HIF1A 3628/4885 |
| US-20170250347-A1 | ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING A LIQUID MEDIUM | CRY1, NEFM, OR10J3 | TERT 1542/4885STAT3 225/4885HIF1A 4242/4885 |
| US-10454037-B2 | Organic semiconductor composition comprising a liquid medium | CRY1, NEFM, OR10J3 | TERT 1542/4885STAT3 225/4885HIF1A 4242/4885 |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | STOM, SPOP, TTR | TERT 2496/4885STAT3 4044/4885HIF1A 4266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.